Beta‐interferon exposure and onset of secondary progressive multiple sclerosis

BACKGROUND AND PURPOSE: Beta‐interferons (IFNβ) are the most widely prescribed drugs for patients with multiple sclerosis (MS). However, whether or not treatment with IFNβ can delay secondary progressive MS (SPMS) onset remains unknown. Our aim was to examine the association between IFNβ exposure an...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Eur J Neurol
Main Authors: Zhang, T., Shirani, A., Zhao, Y., Karim, M. E., Gustafson, P., Petkau, J., Evans, C., Kingwell, E., van der Kop, M., Zhu, F., Oger, J., Tremlett, H.
Format: Artigo
Jezik:Inglês
Izdano: John Wiley and Sons Inc. 2015
Teme:
Original Articles
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC5008210/
https://ncbi.nlm.nih.gov/pubmed/25846809
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ene.12698
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki